Pasithea Therapeutics Cor... (KTTA)
NASDAQ: KTTA
· Real-Time Price · USD
0.71
0.01 (1.04%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.49%
After-hours: Aug 15, 2025, 07:51 PM EDT
Pasithea Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 976.31K | 976.31K | 976.31K | 976.31K | 240.71K | 459.32K | 472.9K | 486.56K | 260.91K | 42.3K | 28.72K | 15.06K | n/a | n/a | n/a |
Cost of Revenue | 486.22K | 486.77K | 486.74K | 648.99K | 649.95K | 650.37K | 489.46K | 413.67K | 265.55K | 115.81K | 131.78K | 45.31K | 30.21K | 17.27K | n/a | n/a | n/a |
Gross Profit | -323.96K | -324.51K | 489.57K | 327.31K | 326.35K | 325.93K | -248.75K | 45.65K | 207.35K | 370.75K | 129.13K | -3.01K | -1.49K | -2.21K | n/a | n/a | n/a |
Operating Income | -13.89M | -14.25M | -16.14M | -16.92M | -16.81M | -15.98M | -15.91M | -15.98M | -15.23M | -14.42M | -11.3M | -8.71M | -6.36M | -4.51M | -2.6M | -1.34M | -611.09K |
Interest Income | 317.21K | 423.18K | 515.53K | 572.19K | 574.97K | 421.76K | 249.03K | 117.29K | 102.00 | 102.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.61M | -13.9M | -15.76M | -16.37M | -16.1M | -15.51M | -15.59M | -16.17M | -15.23M | -13.54M | -7.79M | -5.13M | -3.2M | -2.17M | -2.85M | -1.34M | -611.09K |
Net Income | -13.61M | -13.9M | -15.78M | -16.39M | -16.28M | -287.56M | -286.41M | -287.39M | -285.44M | -10.26M | -5.73M | -2.67M | -1.58M | -2.17M | -2.85M | -1.34M | -611.09K |
Selling & General & Admin | 6.55M | 6.89M | 6.77M | 7.52M | 7.73M | 7.72M | 10.02M | 10.43M | 11.71M | 12M | 10.01M | 8.71M | 6.36M | 4.51M | 2.6M | 1.34M | 611.09K |
Research & Development | 7.18M | 7.2M | 9.04M | 9.08M | 8.75M | 8.1M | 6.14M | 5.79M | 3.76M | 2.67M | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -277 | -277 | -277 | -277 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.57M | 13.93M | 15.81M | 16.6M | 16.48M | 15.82M | 16.15M | 16.22M | 15.47M | 14.66M | 11.29M | 8.71M | 6.36M | 4.51M | 2.6M | 1.34M | 611.09K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 6.39K | 6.49K | 6.49K | 6.49K | 102.00 | n/a | 508.00 | 508.00 | 508.00 | 508.00 | n/a | n/a |
Selling & Marketing Expenses | -3.55M | -2.29B | -10.17B | -10.17B | -10.17B | -7.88B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.89M | 14.25M | 16.14M | 16.92M | 16.81M | 15.98M | 16.15M | 16.22M | 15.48M | 14.69M | 11.34M | 8.76M | 6.39M | 4.52M | 2.6M | 1.34M | 611.09K |
Income Tax Expense | -2 | n/a | 16.9K | 16.9K | 16.9K | 271.89M | 270.65M | 270.65M | 269.81M | -3.67M | -2.46M | -2.46M | -1.62M | 20.00 | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.1M | 1.1M | 1.04M | 1.04M | 1.04M | 1.04M | 1.26M | 1.31M | 1.3M | 1.3M | 1.33M | 1.17M | 1.15M | 1.15M | 660.42K | 688.92K | 688.92K |
Shares Outstanding (Diluted) | 1.1M | 1.1M | 1.04M | 1.04M | 1.04M | 1.04M | 1.26M | 1.31M | 1.3M | 1.3M | 1.33M | 1.17M | 1.15M | 1.15M | 660.42K | 688.92K | 688.92K |
EPS (Basic) | -12.73 | -13.18 | -15.13 | -15.13 | -14.3 | -221.65 | -219.8 | -220.38 | -219.77 | -10.09 | -6.54 | -5.4 | -4.19 | -3.62 | -4.3 | -2.01 | -0.95 |
EPS (Diluted) | -12.73 | -13.18 | -15.13 | -15.13 | -14.3 | -221.65 | -219.8 | -220.38 | -219.77 | -10.09 | -6.54 | -5.4 | -4.19 | -3.62 | -4.3 | -2.01 | -0.95 |
EBITDA | -13.12M | -13.6M | -15.49M | -16.27M | -16.16M | -15.38M | -14.43M | -14.66M | -14.07M | -13.38M | -6.74M | -4.16M | -1.8M | 50.31K | -2.55M | -1.29M | -563.58K |
EBIT | -13.77M | -14.25M | -16.14M | -16.92M | -16.81M | -16.03M | -15.08M | -15.14M | -13.93M | -11.96M | -7.13M | -4.55M | -2.66M | -1.92M | -2.6M | -1.34M | -611.09K |
Depreciation & Amortization | 648.48K | 649.03K | 648.99K | 648.99K | 649.95K | 650.37K | 562.37K | 400.11K | -174.02K | -1.12M | 1.4M | 1.45M | 1.92M | 2.75M | 212.53K | 211.28K | 155.47K |